Welcome to Medpharm Publications

Medpharm Publications was founded in 1988 and has established itself as the largest medical and pharmaceutical journal publisher in South Africa.

With a publications list of more than ten titles comprising of over fifty journal editions, Medpharm Publications reach more than 40 000 healthcare workers countrywide with printed editions, and has established a global audience with the online editions.

The majority of Medpharm Publications’ journals are associated with professional or scholarly societies and acts as the official South African mouthpiece in the associated discipline. All journals are web-based, most of which are fully peer-reviewed, with five titles accredited by the South African Department of Higher Education and Training (DHET) to earn research subsidies for academic departments.

As a publisher, passionate about journal publishing, we believe that South African researchers and clinicians can and will make a significant contribution to world medical literature.

Brunel Laboratoria and Avid Brands join forces to strengthen South African healthcare and personal-care offering

Johannesburg, South Africa – Brunel Laboratoria (Pty) Ltd has announced the commencement of the operational integration of Avid Brands S.A. into the business.

STRESS MAY BE FUELING SA’s METABOLIC DISEASE RISK

Chronic stress may be doing far more than affecting South Africans’ mental health – it could be contributing to the country’s growing burden of obesity, diabetes and other metabolic disorders, many of which are also major risk factors for cardiovascular disease (CVD).

Sanofi and UNICEF partner to reach unvaccinated children in Eastern Cape

Immunisation for Every Child programme will help health teams find children missed by routine immunisation

Wits University liver transplant programme reaches 1 000th transplant milestone

Johannesburg, 30 July 2026: The Wits University Liver Transplant Programme has reached its 1 000th liver transplant, marking a defining milestone for South African medicine and for one of Africa’s most comprehensive transplant programmes.

Cipla announces voluntary licensing agreement relating to investigational HIV prevention candidate

Cipla announces voluntary licensing agreement relating to investigational HIV prevention candidate Cape Town, South Africa – July 2026: Through Cipla's voluntary licensing agreement with Merck (MSD), Cipla may support potential future access to generic alimatravir, an...